INTRODUCTION: Identifying successful smoking treatment interventions and methods of delivery is critical given the smoking rates among HIV-positive populations and the medical implications of smoking in this population. This study compared the efficacy of 3 smoking cessation interventions provided in HIV clinical treatment settings. METHODS: Following a baseline assessment, 209 HIV-positive smokers were randomly assigned to 1 of 3 conditions in a parallel group design. Treatment conditions were individual counseling plus nicotine replacement treatment (NRT), a computer-based Internet smoking treatment plus NRT, and self-help plus NRT. Smoking status was determined at follow-up assessments completed at 12, 24, 36, and 52 weeks following treatment initiation. RESULTS:Cessation rates ranged from 15% to 29%; however, no statistically significant differences in abstinence were found among the treatment conditions over time. Those employed, those who reported a greater desire to quit, or those with lower mood disturbance scores were more likely to achieve abstinence (p < .01). The number of cigarettes participants reported smoking in the 24hr prior to each assessment significantly declined over time (p < .001). CONCLUSIONS: Although we found no differences in abstinence rates across groups, the results indicate that integration of smoking cessation interventions is feasible in HIV clinical treatment settings, and cessation results are promising. The overall abstinence rates we report are comparable to those found in similar treatment studies across multiple populations. Further research is warranted.
RCT Entities:
INTRODUCTION: Identifying successful smoking treatment interventions and methods of delivery is critical given the smoking rates among HIV-positive populations and the medical implications of smoking in this population. This study compared the efficacy of 3 smoking cessation interventions provided in HIV clinical treatment settings. METHODS: Following a baseline assessment, 209 HIV-positive smokers were randomly assigned to 1 of 3 conditions in a parallel group design. Treatment conditions were individual counseling plus nicotine replacement treatment (NRT), a computer-based Internet smoking treatment plus NRT, and self-help plus NRT. Smoking status was determined at follow-up assessments completed at 12, 24, 36, and 52 weeks following treatment initiation. RESULTS: Cessation rates ranged from 15% to 29%; however, no statistically significant differences in abstinence were found among the treatment conditions over time. Those employed, those who reported a greater desire to quit, or those with lower mood disturbance scores were more likely to achieve abstinence (p < .01). The number of cigarettes participants reported smoking in the 24hr prior to each assessment significantly declined over time (p < .001). CONCLUSIONS: Although we found no differences in abstinence rates across groups, the results indicate that integration of smoking cessation interventions is feasible in HIV clinical treatment settings, and cessation results are promising. The overall abstinence rates we report are comparable to those found in similar treatment studies across multiple populations. Further research is warranted.
Authors: Julia H Arnsten; Xuan Li; Yuko Mizuno; Amy R Knowlton; Marc N Gourevitch; Kathleen Handley; Kelly R Knight; Lisa R Metsch Journal: J Acquir Immune Defic Syndr Date: 2007-11-01 Impact factor: 3.731
Authors: Mallory O Johnson; Torsten B Neilands; Samantha E Dilworth; Stephen F Morin; Robert H Remien; Margaret A Chesney Journal: J Behav Med Date: 2007-06-23
Authors: D N Burns; A Kramer; F Yellin; D Fuchs; H Wachter; R A DiGioia; W C Sanchez; R J Grossman; F M Gordin; R J Biggar Journal: J Acquir Immune Defic Syndr (1988) Date: 1991
Authors: Sharon M Hall; Gary L Humfleet; Ricardo F Muñoz; Victor I Reus; Julie A Robbins; Judith J Prochaska Journal: Addiction Date: 2009-04-09 Impact factor: 6.526
Authors: John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan Journal: Nicotine Tob Res Date: 2003-02 Impact factor: 4.244
Authors: Kristin L Schneider; Donald Hedeker; Katherine C Bailey; Jessica W Cook; Bonnie Spring Journal: Nicotine Tob Res Date: 2010-01-25 Impact factor: 4.244
Authors: Jonathan Shuter; Alyson B Moadel; Ryung S Kim; Andrea H Weinberger; Cassandra A Stanton Journal: Nicotine Tob Res Date: 2014-08-23 Impact factor: 4.244
Authors: D R Bailey Miles; Usama Bilal; Heidi E Hutton; Bryan Lau; Catherine R Lesko; Anthony Fojo; Mary E McCaul; Jeanne Keruly; Richard D Moore; Geetanjali Chander Journal: J Health Care Poor Underserved Date: 2019
Authors: Karen L Cropsey; James H Willig; Michael J Mugavero; Heidi M Crane; Cheryl McCullumsmith; Sarah Lawrence; James L Raper; W Christopher Mathews; Stephen Boswell; Mari M Kitahata; Joseph E Schumacher; Michael S Saag Journal: J Addict Med Date: 2016 Jan-Feb Impact factor: 3.702
Authors: Joan S Tucker; William G Shadel; Frank H Galvan; Diana Naranjo; Christian Lopez; Claude Setodji Journal: Psychol Addict Behav Date: 2016-10-13
Authors: Conall O'Cleirigh; Sarah E Valentine; Megan Pinkston; Debra Herman; C Andres Bedoya; Janna R Gordon; Steven A Safren Journal: AIDS Behav Date: 2015-01
Authors: Pamela Valera; F Joseph McClernon; Greer Burkholder; Michael J Mugavero; James Willig; Conall O'Cleirigh; Karen L Cropsey Journal: AIDS Behav Date: 2017-07